Bioassay-directed separation of the light petroleum and methylene chloride extracts of the root tuber of Curcuma wenyujin Y. H. Chen et C. Ling against five cell lines led to the isolation of one hexane derivative, crotepoxide (1), four sesquiterpenes, 4-epi-curcumenol (2), curcumenol (3), curcumadiol (4), and gweicurculactone (5), and three curcuminoids, curcumin (6), demethoxy-curcumin (7), and bisdemethoxycurcumin (8). Compounds 1-5 have not been found previously in C. wenyujin; compounds 2 and 3 were obtained as an epimeric mixture. The structures of the compounds were established on the basis of NMR spectroscopic data. When tested for cytotoxity against cell lines HL-60, HepG2, K562, KB and MCF-7, compounds 5-8 showed better antitumor activity than the others.
The genus Curcuma contains about 70 species of rhizomateous herbs distributed around the world. About 20 species occur in China, of which a few have been used in traditional Chinese medicine for a long time. Some of them are rich in compounds with antineoplastic, anti-inflammatory, antioxidant and antiplatelet properties [1] [2] [3] . We have made a chemical and pharmacological study of C. wenyujin Y.H. Chen et C. Ling, which is distributed in South China and has been used for the treatment of jaundice, epilepsy, dysmenorrhea, thoracicabdominal pain and hematuria [4] [5] [6] . In the light petroleum extract, sesquiterpenes and curcuminoids were detected, but many of these have not been fully characterized [7, 8] , and pharmacological information on the extract and its components is lacking. We herein describe the details of the isolation and structure elucidation, as well as the cytotoxic activity of all the isolated compounds.
With the aim of characterizing the chemical profile of C. wenyujin and of identifying the active compounds, we obtained large samples of ethanol extracts. The root tuber extract was selected for bioassay-guided fraction on the basis of its activity against the five cell lines. The cytotoxicity in the extract was concentrated in the light petroleum and methylene chloride fractions. The light petroleum fraction was fractioned over an orthovoltage silica gel column to furnish twenty-four fractions, which were purified by C-18 HPLC to yield crotepoxide (1), 4-epi-curcumenol (2/3), curcumadiol (4) and compound 5. Similarly, the methylene chloride fraction yielded curcumin (6), demethoxycurcumin (7), and bisdemethoxycurcumin (8); compounds 2 and 3 were obtained as an epimeric mixture. Compound 5 was shown to be gweicurculactone. Our 2D NMR spectroscopic results for this compound show that some of the assignments made when it was first reported [14] need to be corrected. The changes necessary are for the C(H)-13, 14, and 15 signals ( Table 1 ). The structures of the others compounds were determined by examination of their spectra (1D and 2D NMR) and by comparison of these with published data [9] [10] [11] [12] [13] [14] [15] . Compounds 1-5 have not been found previously in C.wenyujin [16] . 10' The cytotoxic activities of the isolated compounds were tested against the cell lines HL-60, HepG2, K562, KB and MCF-7. The results (Table 2) showed that the curcuminoid compounds 6-8 had the best activity against these cell lines, although compound 5 expressed the best overall activity of the eight compounds. However, the IC 50 values of sesquiterpenoids 2-4 and compound 1 were more than 50 μg/mL and showed weak activity against the various cell lines. The above results suggest that the main antitumor active constituents of C. wenyujin were the curcuminoid compounds.
Experimental
General: Optical rotations were measured in a JASCO P-1030 polarimeter, IR spectra were recorded in a Spectrum BRUKER VECTOR 22 (KBr). The 1 H-and 13 C-NMR, HMQC and HMBC spectra were recorded on a Bruker Biospin AMX 400 MHz FT spectrometer. Silica gel (300-400 mesh; Qingdao Chemical Group; Qingdao, China) was employed for 
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Extraction and isolation: Dried, root tuber of C. wenyujin (10 kg) was extracted with 95% EtOH (4×80 L) to give 247 g dry extractive. After suspension in H 2 O (500 mL), the mixture was sequentially partitioned with light petroleum (3×500 mL), CH 2 Cl 2 (3×500 mL), and n-BuOH (3×500 mL). On removal of the solvents, the light petroleum, CH 2 Cl 2, n-BuOH and H 2 O fractions yielded 31.3, 95.1, 21.8, and 99.1 g of extractive, respectively.
The light petroleum extract (31.3 g) was fractionated by column chromatography (5×60 cm) on an orthovoltage silica gel column using light petroleumEtOAc (10:1) to furnish 24 fractions (18A to 18X, 1000 mL each). Fr. 18I gave pure 1 (12 mg) after recrystallization from light petroleum. Fr. 18C and 18L were fractioned by column chromatography (3.5×50cm) on an orthovoltage reverse phase ODS column using MeOH-H 2 O (4:6) and MeOH-H 2 O (3:10) to furnish 12 (43A to 43L, 500 mL each ) and 13 (58A to 58M, 500 mL each) fractions, respectively. Subfraction 43G was subjected to HPLC separation (Agilent 1100, ZORBAX SB-C18 column, 21.2×250 mm, 7 μm; flow rate: 10 mL/min; detection, DAD absorption at 203, 254 nm) and, on elution with 70% acetonitrile-H 2 O, yielded compounds 2 and 3 (24 mg, t R = 7.5 min). Further purification of subfractions 58F and 43E were carried out by C-18 HPLC (Agilent 1100, ZORBAX SB-C18, 21.2×250 mm, 7 μm; flow rate: 10 mL/min; detection, DAD absorption at 203, 254 nm), eluting with 50% acetonitrile-H 2 O and 70% acetonitrile-H 2 O to yield compounds 4 (7 mg, t R = 11.1 min, from subfraction 43F) and 5 (8 mg, t R = 9.2 min, from subfraction 58F), respectively. The methylene chloride extract (95.1 g) was fractioned by column chromatography (5×60 cm) on an orthovoltage silica gel column, eluting with 20:1, 10:1, 5:1, 3:1, 1:1, 1:2, 1:4 light petroleum-EtOAc (5L each) and EtOAc (3 L). The collected fractions (1L each) were combined to yield fractions 15A-15p. Fr. 15V-15b (eluted with 1:1 light petroleum-EtOAc) was further separated by ODS column chromatography, eluting with a CH 2 Cl 2 -MeOH gradient to give fractions 19A-19O. Fr. 19E (500 mg, eluted with CH 2 Cl 2 ) and 19I (247 mg, eluted with CH 2 Cl 2 ) yielded 6 (67 mg) and 7 (40 mg), after recrystallization. Fr. 19L (148 mg, eluted with 25:1 CH 2 Cl 2 -MeOH) was fractionated by HPLC (Agilent 1100, ZORBAX SB-C18, 21.2×250 mm, 7 μm; flow rate: 10 mL/min; detection, DAD absorption at 203, 254 nm), eluting with 70% acetonitrile-H 2 O, to provide pure 8 (28 mg, t R =12 min).
Cell cultures and cytotoxicity analysis:
The human hepatocarcinoma cell lines HepG2 and MFC-7 were cultured in DMEM medium (Gibco BRL) with 3.7 g/L sodium bicarbonate, supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino acids, and seeding at a density of no more than 10 6 cells/mL. The human acute myeloid leukemia cell line, HL-60, and human chronic myelogenous leukemia cell line, K562, were maintained in RPMI-1640 medium (Gibco BRL) with 3.7 g/L sodium bicarbonate, supplemented with 10% heat-inactivated FBS.
In the cytotoxicity assays with HepG2, K562 and MCF-7 cell lines, adriamycin, at a concentration of 4 μg/mL, was chosen as the reference drug, while for HL60 it was platinol, also at a final concentration of 4μg/mL. All the above cell lines, purchased from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China), were seeded in 96-well tissue culture plates, and maintained in a humidified atmosphere of 5% CO 2 and 95% air at 37 o C for 3-6 days before experimentation.
The cytotoxicity of all tested samples and compounds was assayed using the in vitro methyl thiazolyl tetrazolium (MTT) reduction assay in 96-well microtiter plates. Altogether, five cell lines were employed, including Hep-G2 (human hepatocellular carcinoma), HL-60 (human promyelocytic leukemia), K-562 (human chronic myelogenous leukemia), KB (human epidermoid carcinoma in the mouth) and MCF-7 (human breast adenocarcinoma). Briefly, cells in a logarithimic growth phase were harvested, diluted to 2×10 3 cells/mL with fresh medium and gently mixed. Test compound was dissolved in DMSO (concentration 50 mg/mL) and this solution (0.88 μL) was added to the fresh medium (220 μL/well), and then the dilution (50 μL) and cell suspension (150 μL) were transferred into the microtiter plates (concentration 50 μg/mL). If the compound were active at 50 μg/mL, a series of solutions were prepared by two-fold dilution, and exposed to cells, as mentioned above, in order to obtain IC 50 values. Plates were incubated at 37 o C in a 5% CO 2 atmosphere for 72 h. After the incubation period, 10% methyl thiazolyl tetrazolium (MTT) was added and incubated at 37 o C for 4 h. The pure formazan product was solubilized in 150 μL DMSO for 10 min at room temperature and then the plate was read at 550 nm in a plate reader. Four wells were used for each drug concentration, and all the reported experiments were performed at least four times. 
